VYNE Therapeutics, Inc. (VYNE)
0.404
+0.03
(+7.22%)
USD |
NASDAQ |
Dec 10, 16:00
0.404
0.00 (0.00%)
After-Hours: 06:46
VYNE Therapeutics Cash from Investing (Quarterly): 4.402M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | -100.25M |
| NovaBay Pharmaceuticals, Inc. | 0.00 |
| Palatin Technologies, Inc. | 0.00 |
| Theriva Biologics, Inc. | -0.019M |
| Oragenics, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.096M |
| Cash from Financing (Quarterly) | -0.007M |
| Free Cash Flow | -38.48M |
| Free Cash Flow Per Share (Quarterly) | -0.1658 |
| Free Cash Flow to Equity (Quarterly) | -7.071M |
| Free Cash Flow to Firm (Quarterly) | -7.096M |
| Free Cash Flow Yield | -223.0% |